The CVC Scientific Advisory Committee, composed of a diverse group of renowned clinical immunologists from the world's top institutions, guides the Clinical Accelerator's scientific strategy and clinical trial selection.
The CVC Management Team, which includes key executives from both CRI and Ludwig Cancer Research, is responsible for a) the CVC's year-round operations and administration, b) facilitating scientific discussions among CVC members, and c) the program's investment, intellectual property, clinical trial, and biopharma partnership managements.
CVC Scientific Advisory Committee
Jedd D. Wolchok, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center and Ludwig Cancer Research
Jonathan Cebon, Ph.D., FRACP
Ludwig Cancer Research, Austin Health
George Coukos, M.D., Ph.D.
CHUV and Ludwig Cancer Research
Glenn Dranoff, M.D.
Dana-Farber Cancer Institute, Harvard Medical School
Lawrence Fong, M.D.
University of California, San Francisco
Elizabeth M. Jaffee, M.D.
Johns Hopkins Medicine
Carl H. June, M.D.
University of Pennsylvania
Alexander Knuth, M.D.
National Center for Cancer Care and Research
Kunle Odunsi, M.D., Ph.D.
Roswell Park Cancer Institute
Craig L. Slingluff Jr., M.D.
University of Virginia School of Medicine
CVC Management Team